PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

A bright idea: Tiny injectable LEDs help neuroscientists study the brain

2013-04-12
(Press-News.org) CHAMPAIGN, Ill. — A new class of tiny, injectable LEDs is illuminating the deep mysteries of the brain.

Researchers at the University of Illinois at Urbana-Champaign and Washington University in St. Louis developed ultrathin, flexible optoelectronic devices – including LEDs the size of individual neurons – that are lighting the way for neuroscientists in the field of optogenetics and beyond.

Led by John A. Rogers, the Swanlund professor of materials science and engineering at the U. of I., and Michael R. Bruchas, a professor of anesthesiology at Washington University, the researchers will publish their work in the April 12 issue of the journal Science.

"These materials and device structures open up new ways to integrate semiconductor components directly into the brain," said Rogers, who directs the Frederick Seitz Materials Research Laboratory at the U. of I. "More generally, the ideas establish a paradigm for delivering sophisticated forms of electronics into the body: ultra-miniaturized devices that are injected into and provide direct interaction with the depths of the tissue."

The researchers demonstrated the first application of their devices in optogenetics, a new area of neuroscience that uses light to stimulate targeted neural pathways in the brain. The procedure involves genetically programming specific neurons to respond to light. Optogenetics allows researchers to study precise brain functions in isolation in ways that are impossible with electrical stimulation, which affects neurons throughout a broad area, or with drugs, which saturate the whole brain.

Optogenetics experiments with mice illustrate the ability to train complex behaviors without physical reward, and to alleviate certain anxiety responses. Yet fundamental insights into the structure and function of the brain that emerge from such studies could have implications for treatment of Alzheimer's, Parkinson's, depression, anxiety and other neurological disorders.

While a number of important neural pathways now can be studied by optogenetics, researchers continue to struggle with the engineering challenge of delivering light to precise regions deep within the brain. The most widely used methods tether the animals to lasers with fiber-optic cables embedded in the skull and brain – an invasive procedure that also limits movements, affects natural behaviors and prevents study of social interactions.

The newly developed technologies bypass these limitations with specially designed powerful LEDs – among the world's smallest, with sizes comparable to single cells – that are injected into the brain to provide direct illumination and precise control. The devices are printed onto the tip end of a thin, flexible plastic ribbon – thinner than a human hair and narrower than the eye of a needle – that can insert deep into the brain with very little stress to tissue.

"One of the big issues with implanting something into the brain is the potential damage it can cause," Bruchas said. "These devices are specifically designed to minimize those problems, and they are much more effective than traditional approaches."

The active devices include not only LEDs but also various sensors and electrodes that are delivered into the brain with a thin, releasable micro-injection needle. The ribbon connects the devices to a wireless antenna and a rectifier circuit that harvests radio frequency energy to power the devices. This module mounts on top of the head and can be unplugged from the ribbon when not in use.

"Study of complex behaviors, social interactions and natural responses demands technologies that impose minimal constraints," Rogers said. "The systems we have developed allow the animals to move freely and to interact with one another in a natural way, but at the same time provide full, precise control over the delivery of light into the depth of the brain."

The complete device platform includes LEDs, temperature and light sensors, microscale heaters and electrodes that can both stimulate and record electrical activity. These components enable many other important functions – for example, researchers can measure the electrical activity that results from light stimulation, giving additional insight into complex neural circuits and interactions within the brain.

The breadth of device options suggests that this wireless, injectable platform could be used for other types of neuroscience studies – or even applied to other organs. For example, Rogers' team has developed related devices for stimulating peripheral nerves in the leg as a potential route to pain management. They also have built devices with LEDs of multiple colors, so that several neural circuits can be studied with a single injected system.

"These cellular-scale, injectable devices represent frontier technologies with potentially broad implications," Rogers said. His group is known for its success in the development of soft sheets of sophisticated electronics that wrap the brain or the heart or that adhere directly to the skin.

"But none of those devices penetrates into the depth of tissue," Rogers said. "That's the challenge that we're trying to address with this new approach. Many cases, ranging from fundamental studies to clinical interventions, demand access directly into the depth. This is just the first of many examples of injectable semiconductor microdevices that will follow."

The National Institutes of Health and the U.S. Department of Energy supported this work. Rogers is also affiliated with the Micro and Nanotechnology Laboratory; the Beckman Institute for Advanced Science and Technology; and the departments of bioengineering, chemistry, electrical and computer engineering, and mechanical science and engineering at the U. of I.

###

See John Rodgers explain the injectable devices and their use in optogenetics at: http://www.youtube.com/watch?v=MTy9IvX8Occ. END



ELSE PRESS RELEASES FROM THIS DATE:

Research examines effects of opioids on patients with sickle cell disease

2013-04-12
April 11, 2013, Fort Lauderdale, Fla. -- Researchers from Virginia Commonwealth University (VCU) sought to shed light on the biopsychosocial and spiritual effects of taking prescribed opioids to treat noncancer pain. Such questions have received little examination and impact the challenging decision of when and how to use opioids, the study authors wrote in a scientific poster presented today at the 29th Annual Meeting of the American Academy of Pain Medicine. They found that taking opioids had many and diverse consequences for patients in terms of biological, psychological, ...

Study: Pain improves during first year but mental-health problems linger

2013-04-12
April 11, 2013, Fort Lauderdale, Fla. -- Veterans who sustained major limb injuries during combat reported little improvement in symptoms of depression, anxiety, post-traumatic stress disorder (PTSD) and other mental-health problems up to 2 years post injury, according to research presented today. In contrast, pain showed the most improvement 3-6 months after acute hospitalization, and then leveled off after 1 year. The investigative team, led by Rollin M. Gallagher, MD, MPH, reported results during a poster session at the 29th Annual Meeting of the American Academy of ...

Experimental study suggests bone-marrow grafts show promise for some sufferers of low-back pain

2013-04-12
April 11, 2013, Fort Lauderdale, Fla. -- A new study suggests that the type of bio-cellular grafts increasingly used by surgeons to repair damaged tissue may be useful for treating low-back pain (LBP). However, not all sufferers responded equally to the novel therapy. Results reported today at the 29th Annual Meeting of the American Academy of Pain Medicine ranged from complete pain relief to no improvement. The procedure involved injecting a concentrated form of bone-marrow cellular aspirate into lumbar discs in patients with clinical and objective evidence of disc ...

High-dose opioids disturb hormones long-term, but mental and physiologic function improves

2013-04-12
April 11, 2013, Fort Lauderdale, Fla. -- Half of patients on high-dose, long-term opioid therapy had hormonal disturbances or signs of inflammation, while 100 percent reported improved pain control and mental outlook, new research shows. The results, reported today at the 29th Annual Meeting of the American Academy of Pain Medicine, present rare data on the effects of opioids beyond 10 years. Most clinical trials that examine opioid use are of short duration, and little is known about long-term outcomes, particularly in patients who suffer from noncancer pain. The 40 ...

Full range of treatment settings and their effects on radiofrequency heat lesion size

2013-04-12
April 11, 2013, Fort Lauderdale, Fla. -- Changing the parameters used to deliver radiofrequency (RF) treatment greatly affects the size of the resulting heat lesion, researchers reported today in a study expected to deliver greater precision and more treatment options in interventional pain management. Results were presented at the 29th Annual Meeting of the American Academy of Pain Medicine. "This is the most comprehensive study of radiofrequency heat lesion size for pain management to date," said the study's lead author, Eric Cosman Jr., PhD, scientific director of ...

New techniques reduce the complications of spinal cord stimulator implant

2013-04-12
April 11, 2013, Fort Lauderdale, Fla. -- Two innovative techniques in the placement of an implanted spinal cord stimulator (SCS) are expected to reduce common complications at the implant site, according to new research revealed today. Results from a case series highlighted an advanced lead anchoring technique and the emerging technology of using large single-port introducers, which enable placement of multiple neurostimulation leads through a single needle-entry point. Neurostimulation leads are used in SCS therapy for the management of chronic pain. The researchers ...

Web-based tools found to enhance recruitment and prescreening for clinical pain trials

2013-04-12
April 11, 2013, Fort Lauderdale, Fla. -- Researchers are suggesting new ways to use existing Internet tools to recruit more study participants for clinical pain trials and to increase the likelihood they will remain throughout the study period. An innovative website allowed recruiters to reach out broadly to target and recruit potential subjects and to avoid many of the common difficulties of pain research, according to results presented today at the 29th Annual Meeting of the American Academy of Pain Medicine. Research is important to establish which therapies are safe ...

Research shows promise for microwave ablation (MWA) to relieve painful bone and soft-tissue tumors

2013-04-12
April 11, 2013, Fort Lauderdale, Fla. -- First-of-its-kind research presented today showed microwave ablation (MWA) therapy cut pain in half for patients with painful bone and soft-tissue tumors and took less time to complete than radiofrequency ablation. Pain relief lasted over 4 months on average and up to 15 months in some patients, according to results reported at the 29th Annual Meeting of the American Academy of Pain Medicine. Approximately 10,600 new cases of soft-tissue sarcoma and 2,570 new cases of bone sarcoma were diagnosed in the United States in 2009, according ...

Researchers measure reaction rates of second key atmospheric component

2013-04-12
LIVERMORE, Calif.— Researchers at Sandia National Laboratories' Combustion Research Facility, the University of Manchester, Bristol University, University of Southampton and Hong Kong Polytechnic have successfully measured reaction rates of a second Criegee intermediate, CH3CHOO, and proven that the reactivity of the atmospheric chemical depends strongly on which way the molecule is twisted. The measurements will provide further insight into hydrocarbon combustion and atmospheric chemistry. A paper describing the research findings titled "Direct Measurements of Conformer-Dependent ...

Are 4 antenatal visits enough?

2013-04-12
Reanalysis of the World Health Organization's Antenatal Care Trial (WHOACT) shows that there is an increased risk of fetal death at between 32 and 36 weeks for women who have a reduced antenatal care package, finds research published in BioMed Central's open access journal Reproductive Health. Original analysis of the WHOACT concluded that reducing antenatal visits of low risk women from eight to four was not detrimental to their or their babies' health and could cut costs. Based on this advice some countries have lowered the number of routine antenatal visits . However, ...

LAST 30 PRESS RELEASES:

Stand up to cancer adds new expertise to scientific advisory committee

‘You don’t just throw them in a box.’ Archaeologists, Indigenous scholars call on museums to better care for animal remains

Can AI tell us if those Zoom calls are flowing smoothly? New study gives a thumbs up

The Mount Sinai Hospital ranked among world’s best in Newsweek/Statista rankings

Research shows humans have a long way to go in understanding a dog’s emotions

Discovery: The great whale pee funnel

Team of computer engineers develops AI tool to make genetic research more comprehensive

Are volcanoes behind the oxygen we breathe?

The two faces of liquid water

The Biodiversity Data Journal launches its own data portal on GBIF

Do firefighters face a higher brain cancer risk associated with gene mutations caused by chemical exposure?

Less than half of parents think they have accurate information about bird flu

Common approaches for assessing business impact on biodiversity are powerful, but often insufficient for strategy design

Can a joke make science more trustworthy?

Hiring strategies

Growing consumption of the American eel may lead to it being critically endangered like its European counterpart

KIST develops high-performance sensor based on two-dimensional semiconductor

New study links sleep debt and night shifts to increased infection risk among nurses

Megalodon’s body size and form uncover why certain aquatic vertebrates can achieve gigantism

A longer, sleeker super predator: Megalodon’s true form

Walking, moving more may lower risk of cardiovascular death for women with cancer history

Intracortical neural interfaces: Advancing technologies for freely moving animals

Post-LLM era: New horizons for AI with knowledge, collaboration, and co-evolution

“Sloshing” from celestial collisions solves mystery of how galactic clusters stay hot

Children poisoned by the synthetic opioid, fentanyl, has risen in the U.S. – eight years of national data shows

USC researchers observe mice may have a form of first aid

VUMC to develop AI technology for therapeutic antibody discovery

Unlocking the hidden proteome: The role of coding circular RNA in cancer

Advancing lung cancer treatment: Understanding the differences between LUAD and LUSC

Study reveals widening heart disease disparities in the US

[Press-News.org] A bright idea: Tiny injectable LEDs help neuroscientists study the brain